The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis. (PubMed, Clin Microbiol Infect) - Aug 28, 2025 - "EBV reactivation had no apparent correlation with letermovir prophylaxis, was associated with previous CMV reactivation, and had no significant impact on mortality."
Journal • Acute Myelogenous Leukemia • Chronic Myelomonocytic Leukemia • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Graft versus Host Disease • Hematological Malignancies • Immunology • Infectious Disease • Leukemia • Oncology • Transplantation
|
|
Amanda Olson; Amy Spallone; Anthony Febres-Aldana; Elizabeth J Shpall; Ella J Ariza-Heredia; Fareed Khawaja; Gabriela Rondon; George Chen; Katayoun Rezvani; Marilyne Daher; Micah Bhatti; Richard Champlin; Roy F Chemaly; Tali Shafat; Terri Lynn Shigle; Ying Jiang
|